Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Balta, Emre [VerfasserIn]   i
 Wabnitz, Guido H. [VerfasserIn]   i
 Samstag, Yvonne [VerfasserIn]   i
Titel:Hijacked immune cells in the tumor microenvironment
Titelzusatz:molecular mechanisms of immunosuppression and cues to improve T cell-based immunotherapy of solid tumors
Verf.angabe:Emre Balta, Guido H. Wabnitz and Yvonne Samstag
E-Jahr:2021
Jahr:27 May 2021
Umfang:27 S.
Teil:volume:22
 year:2021
 number:11
 elocationid:5736
 pages:1-27
 extent:27
Fussnoten:Gesehen am 26.07.2021
Titel Quelle:Enthalten in: International journal of molecular sciences
Ort Quelle:Basel : Molecular Diversity Preservation International, 2000
Jahr Quelle:2021
Band/Heft Quelle:22(2021), 11, Artikel-ID 5736, Seite 1-27
ISSN Quelle:1422-0067
 1661-6596
Abstract:The understanding of the tumor microenvironment (TME) has been expanding in recent years in the context of interactions among different cell types, through direct cell-cell communication as well as through soluble factors. It has become evident that the development of a successful antitumor response depends on several TME factors. In this context, the number, type, and subsets of immune cells, as well as the functionality, memory, and exhaustion state of leukocytes are key factors of the TME. Both the presence and functionality of immune cells, in particular T cells, are regulated by cellular and soluble factors of the TME. In this regard, one fundamental reason for failure of antitumor responses is hijacked immune cells, which contribute to the immunosuppressive TME in multiple ways. Specifically, reactive oxygen species (ROS), metabolites, and anti-inflammatory cytokines have central roles in generating an immunosuppressive TME. In this review, we focused on recent developments in the immune cell constituents of the TME, and the micromilieu control of antitumor responses. Furthermore, we highlighted the current challenges of T cell-based immunotherapies and potential future strategies to consider for strengthening their effectiveness.
DOI:doi:10.3390/ijms22115736
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.3390/ijms22115736
 Volltext: https://www.mdpi.com/1422-0067/22/11/5736
 DOI: https://doi.org/10.3390/ijms22115736
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Animals
 Biomarkers
 cancer immunotherapy
 CAR T cells
 Humans
 Immunologic Surveillance
 Immunomodulation
 immunosuppression
 Immunotherapy
 Lymphocytes, Tumor-Infiltrating
 Neoplasms
 Neutrophil Infiltration
 Reactive Oxygen Species
 ROS
 T-Lymphocyte Subsets
 T-Lymphocytes
 TILs
 TME
 Treatment Outcome
 Tumor Escape
 Tumor Microenvironment
 Tumor-Associated Macrophages
K10plus-PPN:1764589092
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68763381   QR-Code
zum Seitenanfang